A platinum nanourchin-based multi-enzymatic platform to disrupt mitochondrial function assisted by modulating the intracellular H2O2 homeostasis
Source abstract
Abstract
Endogenous H 2 O 2 sacrifices for diversified therapeutic reactions against tumor. However, the treatment outcome is not always satisfactory owing to the unsustainable H 2 O 2 supply from tumor microenvironment (TME). Herein, a platinum (Pt) nanourchin-based multi-enzymatic platform (referred to PGMA) is established by surface conjugation of glucose oxidase (GOx) capped with manganese carbonyl (MnCO) and loading 3-amino-1,2,4-triazole (3-AT). The mild acidic and H 2 O 2 -rich TME can render the degradation of MnCO, followed by triggering the release of CO gas, 3-AT and Mn 2+/3+ . The resultant GOx exposure initiates intratumoral glucose depletion, which is promoted by the O 2 replenishment through Pt-catalyzed decomposition of H 2 O 2 . Meanwhile, intracellular reactive oxygen species (ROS) level is elevated through Mn 2+/3+ couple-mediated Fenton-like reaction. Hence, CO release-initiated gas therapy , glucose exhaustion-induced tumor starvation and ROS-triggered chemodynamic therapy are committed to realizing a combinatorial disruption effect on mitochondrial function. Importantly, the released 3-AT can inhibit the activity of endogenous catalase , which effectively elevates the intracellular H 2 O 2 level to compensate its consumption and provides incremental reactant for cascade utilizations. Taken together, this study aims to emphasize the importance of intracellular H 2 O 2 balance during H 2 O 2 -depleted therapeutic process, and affords a prime paradigm of applying this strategy for tumor treatment via mitochondrial dysfunction.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. American Heart Association Council on Basic Cardiovascular Sciences, G. Council on Functional, B, Translational, mitochondrial function, biology, and role in disease: a scientific statement from the american heart association10.1161/RES.0000000000000104 ↗
2. Functional mitochondria in health and disease10.3389/fendo.2017.00296 ↗
3. Mitochondrial TCA cycle metabolites control physiology and disease10.1038/s41467-019-13668-3 ↗
4. Mitochondrial dynamics and its involvement in disease10.1146/annurev-pathmechdis-012419-032711 ↗
5. Mitochondria and cancer10.1016/j.cell.2016.07.002 ↗
6. Mitochondrial metabolism and cancer10.1038/cr.2017.155 ↗
7. Comprehensive molecular characterization of mitochondrial genomes in human cancers10.1038/s41588-019-0557-x ↗
8. Targeting mitochondria metabolism for cancer therapy10.1038/nchembio.1712 ↗
9. The mitochondrion as an emerging therapeutic target in cancer10.1016/j.molmed.2019.06.009 ↗
10. Targeting mitochondria as an anticancer strategy10.1186/s40880-019-0412-6 ↗
11. Mitochondrial electron transport chain, ROS generation and uncoupling (Review)
12. Advances in nanomedicine for cancer starvation therapy10.7150/thno.38261 ↗
13. Augmenting tumor-starvation therapy by cancer cell autophagy inhibition10.1002/advs.201902847 ↗
14. Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy10.1021/acsnano.8b00309 ↗
15. Glucose starvation induces mitochondrial fragmentation depending on the dynamin GTPase Dnm1/Drp1 in fission yeast10.1074/jbc.RA119.010185 ↗
16. Inhibition of glucose transporters and glutaminase synergistically impairs tumor cell growth10.1016/j.chembiol.2019.06.005 ↗
17. Glucose oxidase-instructed traceable self-oxygenation/hyperthermia dually enhanced cancer starvation therapy10.7150/thno.40439 ↗
18. Tumor-selective catalytic nanomedicine by nanocatalyst delivery10.1038/s41467-017-00424-8 ↗
19. Glucose oxidase-instructed multimodal synergistic cancer therapy10.1002/adma.202003130 ↗
20. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment10.1039/C7CS00891K ↗
21. Biodegradable manganese-doped calcium phosphate nanotheranostics for traceable cascade reaction-enhanced anti-tumor therapy10.1021/acsnano.9b05836 ↗
22. Janus γ-Fe2O3/SiO2-based nanotheranostics for dual-modal imaging and enhanced synergistic cancer starvation/chemodynamic therapy10.1016/j.scib.2019.12.024 ↗
23. Engineering macromolecular nanocarriers for local delivery of gaseous signaling molecules10.1016/j.addr.2021.114005 ↗
24. Gas-mediated cancer bioimaging and therapy10.1021/acsnano.9b04954 ↗
25. Strategies for engineering advanced nanomedicines for gas therapy of cancer10.1093/nsr/nwaa034 ↗
26. Emerging delivery strategies of carbon monoxide for therapeutic applications: from CO gas to CO releasing nanomaterials10.1002/smll.201904382 ↗
27. Multifunctional SGQDs-CORM@HA nanosheets for bacterial eradication through cascade-activated "nanoknife" effect and photodynamic/CO gas therapy10.1016/j.biomaterials.2021.121084 ↗
28. Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy10.1164/rccm.201606-1275CI ↗
29. Mesoporous polydopamine carrying manganese carbonyl responds to tumor microenvironment for multimodal imaging-guided cancer therapy10.1002/adfm.201900095 ↗
30. Carbon monoxide controllable targeted gas therapy for synergistic anti-inflammation10.1016/j.isci.2020.101483 ↗
31. A novel H2O2 generator for tumor chemotherapy-enhanced CO gas therapy10.3389/fonc.2021.738567 ↗
32. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy10.1038/s41467-019-09566-3 ↗
33. ROS in cancer therapy: the bright side of the moon10.1038/s12276-020-0384-2 ↗
34. The role of reactive oxygen species in tumor treatment and its impact on bone marrow hematopoiesis10.2174/1389450120666191021110208 ↗
35. The double-edged roles of ROS in cancer prevention and therapy10.7150/thno.56747 ↗
36. Biodegradable nanoprodrugs: “delivering” ROS to cancer cells for molecular dynamic therapy10.1002/adma.201904011 ↗
37. Recent progress of chemodynamic therapy-induced combination cancer therapy10.1016/j.nantod.2020.100946 ↗
38. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions10.1002/anie.201805664 ↗
39. Reactive oxygen species (ROS)-based nanomedicine10.1021/acs.chemrev.8b00626 ↗
40. Chemodynamic therapy: tumour microenvironment-mediated fenton and fenton-like reactions10.1002/anie.201805664 ↗
41. Biomedicine meets Fenton chemistry10.1021/acs.chemrev.0c00977 ↗
42. A Mn(III)-sealed metal-organic framework nanosystem for redox-unlocked tumor theranostics10.1021/acsnano.9b00300 ↗
43. Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
44. Bacterial template synthesis of multifunctional nanospindles for glutathione detection and enhanced cancer-specific chemo-chemodynamic therapy10.34133/2020/9301215 ↗
45. Tumor-specific drug release and reactive oxygen species generation for cancer chemo/chemodynamic combination therapy10.1002/advs.201801986 ↗
46. An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy10.1038/s41467-020-15591-4 ↗
47. Nanozyme decorated metal–organic frameworks for enhanced photodynamic therapy10.1021/acsnano.7b07746 ↗
48. An acidity-unlocked magnetic nanoplatform enables self-boosting ROS generation through upregulation of lactate for imaging-guided highly specific chemodynamic therapy10.1002/anie.202014415 ↗
49. Two-photon supramolecular nanoplatform for ratiometric bioimaging10.1021/acs.analchem.9b01455 ↗
50. Smart nanozyme platform with activity-correlated ratiometric molecular imaging for predicting therapeutic effects10.1002/anie.202110427 ↗
51. Light-free generation of singlet oxygen through manganese-thiophene nanosystems for pH-responsive chemiluminescence imaging and tumor therapy
52. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells10.1021/ja511420n ↗
53. Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling
54. Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach10.1515/hsz-2017-0131 ↗
55. Bioinspired construction of a nanozyme-based H2O2 homeostasis disruptor for intensive chemodynamic therapy10.1021/jacs.9b12873 ↗
56. Mesoporous Pt nanospheres with designed pore surface as highly active electrocatalyst10.1039/C5SC03779D ↗
57. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties10.1039/C8NR02278J ↗
58. A novel theranostic nanoplatform based on Pd@Pt-PEG-Ce6 for enhanced photodynamic therapy by modulating tumor hypoxia microenvironment10.1002/adfm.201706310 ↗
59. Illuminating platinum transportation while maximizing therapeutic efficacy by gold nanoclusters via simultaneous near-infrared-I/II imaging and glutathione scavenging10.1021/acsnano.0c05541 ↗
60. Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment10.1007/s10147-020-01666-1 ↗
61. Porous Pt nanospheres incorporated with GOx to enable synergistic oxygen-inductive starvation/electrodynamic tumor therapy10.1002/advs.202001223 ↗
62. Allyl fluorescein ethers as promising fluorescent probes for carbon monoxide imaging in living cells10.1021/acs.analchem.7b00135 ↗